Sus Clinicals

Sus Clinicals accelerates qualification of potentially life-saving cancer therapeutics through our proprietary pig-based preclinical testing services. In collaboration with top research institutions with large animal testing capability, our predictive model can better identify those drugs, diagnostics, and devices which have the highest potential for success in human clinical trials, helping our customers focus their resources and advance to in-market success.